CORONAVIRUS/Taiwan rules out regular use of antiparasitic drug to treat COVID
06/14/2021 06:30 PM
Taipei, June 14 (CNA) As the common antiparasitic ivermectin is being touted as a cure for COVID-19 in many parts of the world, Taiwan's experts on Monday warned against regular use of the drug in COVID-19 treatment, citing a lack of solid evidence.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
![Taiwan reports 51 new COVID-19 cases, including 10 domestic infections]()
Taiwan reports 51 new COVID-19 cases, including 10 domestic infectionsTaiwan on Sunday reported 10 new domestic cases of COVID-19, as well as 41 imported cases, and no new deaths from the disease, according to the Central Epidemic Command Center ...01/16/2022 02:24 PM!['COVID pass' plan by city mayors must protect personal freedom: Minister]()
'COVID pass' plan by city mayors must protect personal freedom: MinisterMinister of Health and Welfare Chen Shih-chung (陳時中) said Saturday that two local governments, which are proposing to adopt the use of a digital COVID-19 certificate for entry to ...01/15/2022 11:04 PM![Over 750,000 appointments made for COVID-19 vaccine booster shot]()
Over 750,000 appointments made for COVID-19 vaccine booster shotMore than 750,000 people had made an appointment for a COVID-19 vaccine booster shot in the first seven hours after the central government's 1922 vaccination website was ...01/15/2022 10:33 PM
Latest
- Society
Hsinchu shopping mall closes due to confirmed COVID-19 case visit
01/16/2022 09:06 PM - Society
COVID-19 patients in Taoyuan visited retailers, rode city buses
01/16/2022 08:59 PM - Society
Migrant workers in Taiwan rally for freedom to change jobs
01/16/2022 08:52 PM - Sports
MLB Pittsburgh Pirates expected to sign Taiwan pitcher Chang Hung-leng
01/16/2022 08:28 PM - Society
Online bookings for COVID-19 vaccines to reopen Tuesday in Taiwan
01/16/2022 07:50 PM
